(NASDAQ: NSTG) Nanostring Technologies's forecast annual revenue growth rate of 67.98% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 243.21%, and while it is forecast to beat the US market's average forecast revenue growth rate of 25.31%.
Nanostring Technologies's revenue in 2023 is $127,262,000.On average, 3 Wall Street analysts forecast NSTG's revenue for 2023 to be $10,002,845,379, with the lowest NSTG revenue forecast at $9,244,971,115, and the highest NSTG revenue forecast at $10,532,660,178.
In 2024, NSTG is forecast to generate $12,504,246,891 in revenue, with the lowest revenue forecast at $11,469,884,449 and the highest revenue forecast at $13,538,656,125.